Synthekine
PrivateLast Round
Series C
Jan 6, 2023
Total Funding Raised
$289.5M
Company Overview
Synthekine is a biotechnology company that develops engineered cytokine therapeutics aimed at creating disease-optimized treatments through targeted protein engineering and immunological insights for cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthekine Comparables
Compare Synthekine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asher Biotherapeutics | 86% | |
| Aulos Bioscience | 85% | |
| Bright Peak Therapeutics | 84% | |
Synthekine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 6, 2023 | ||||
| Series B | Jun 10, 2021 | ||||
| Series A | Sep 17, 2020 |
Synthekine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series C, Series A |
| Deerfield Management | Series C, Series B |
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | Series C, Series B |
| TCG Crossover | Series B |
| Omega Funds | Series C, Series B |
| The Chernin Group | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2025
Presenting initial clinical data for STK-012 at SITC 2025.
- Oct 31, 2025
Initial data for STK-012 will be presented at SITC 2025.
Synthekine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synthekine's valuation, stock price, and market status.